Fox Run Management’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,361
Closed -$292K 1269
2025
Q4
$292K Buy
+32,361
New +$242K 0.05% 702
2024
Q2
Sell
-33,490
Closed -$184K 1109
2024
Q1
$184K Buy
+33,490
New +$153K 0.04% 650

Other funds holding VTYX

Fox Run Management's VTYX Position: Q1 2026 in Review

Fox Run Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 32,361 shares — an estimated $292K sold.

Fox Run Management first reported a position in VTYX in Q1 2024 and held it in 2 quarters. The position peaked at $292K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Fox Run Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 32,361 Ventyx Biosciences shares in Q1 2026, an estimated $292K.
  • Fox Run Management first reported a position in Ventyx Biosciences in Q1 2024 and held it in 2 quarters.
  • Fox Run Management's Ventyx Biosciences position peaked at $292K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.